Virtual Medicinal Product (VMP) - Tiabendazole 500mg/5ml oral suspension sugar free
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Tiabendazole 500mg/5ml oral suspension sugar free | Start Date 25-05-2007 | End Date |
| Previous Name | Previous Name Tiabendazole 500mg/5ml oral suspension | Start Date 14-05-2007 |
End Date
|
Unit Dose & Form Information
- DF Indicator
- Continuous
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Oral suspension
- Ontology Form/Route
- suspension.oral
- Free From
- Sugar-free
- Non-availability Indicator
- Actual Products not Available
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
- P02CA02
| Code | Start Date | End Date |
|---|---|---|
| 41795311000001108 | 12-05-2023 | |
| 371691007 | 14-05-2007 | 11-05-2023 |
VMP Ingredients
| Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
|---|---|---|---|---|
| Tiabendazole | Based on Ingredient Substance | 100 mg | 1 ml |
Name
Tiabendazole
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
100.0
Strength and UOM (Dmr)
1.0
Parent Products
-
VTMTiabendazole
-
VMP(Current) Tiabendazole 500mg/5ml oral suspensi...
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
| Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
|---|---|---|
| 120 ml |